ANI PHARMACEUTICALS, INC Increase (Decrease) in Income Taxes Payable
ANI PHARMACEUTICALS, INC (ANIP) reported Increase (Decrease) in Income Taxes Payable of -$3.77 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2015-05-05
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes payable for the quarter ending 2015-03-31 was -$3.77M, a 10877.14% decline year-over-year.
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes payable for the quarter ending 2014-03-31 was $35.00K.
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes payable for fiscal 2014 was $4.23M, a 21065.00% increase from fiscal 2013.
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes payable for fiscal 2013 was $20.00K.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|
| 2015-03-31 | -$3.77M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $4.23M 10-K · filed 2015-02-23 | |
| 2014-03-31 | $35.00K 10-Q · filed 2015-05-05 | |
| 2013-12-31 | $20.00K 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |